Xinxiang Ruicheng Technology Co., Ltd. (hereinafter referred to as "Ruicheng Technology"), established in 2000 and headquartered in the eastern section of Qinglong Road, Xinxiang Economic Development Zone, is a high-tech enterprise integrating R&D, production, and sales. The company focuses on the development and industrialization of nucleoside and antiviral APIs and vitamin intermediates.